You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康恩貝(600572.SH):完成轉讓JHBP(CY)2448.67萬股股權
格隆匯 03-20 17:15

格隆匯3月20日丨康恩貝(600572.SH)公佈,公司子公司KangJia Medical Technology Limited(中文名:康嘉醫療科技有限公司,以下簡稱“康嘉醫療BVI”)擬以2878.49萬美元的作價將所持有的JHBP (CY) Holdings Limited(以下簡稱“JHBP(CY)”)2448.67萬股股份分別轉讓給上海裕詣企業管理合夥企業(有限合夥)、Long Fast Limited、Puhua CapitalLtd和TRUE MAGIC INVESTMENTS LIMITED,其中上海裕詣企業管理合夥企業(有限合夥)以831.95萬美元受讓707.72萬股股份,Long Fast Limited以299.996萬美元受讓255.2萬股股份,Puhua CapitalLtd以646.54萬美元受讓550萬股股份,TRUE MAGIC INVESTMENTS以1100萬美元受讓935.75萬股股份。

截止2020年2月3日,康嘉醫療BVI已全部收到本次股權轉讓款共計2878.49萬美元。近日,公司接JHBP(CY)通知,JHBP(CY)已完成上述股權轉讓事項的變更登記備案手續,且康嘉醫療BVI已收到JHBP(CY)簽發的新的股東證明。上述股權轉讓事項已完成。現公司仍然通過康嘉醫療BVI間接持有JHBP(CY)2698.39萬股股份,通過Kanghe Medical Technology Limited間接持有JHBP(CY)8862.21萬股股份,合計間接持有JHBP(CY)1.16億股股份,佔截至本公告日JHBP(CY)已發行股份的20.7201%,從而仍間接持有嘉和生物藥業有限公司20.7201%股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account